Search research articles
Contact Us
Filters
Showing results (51-60 of 108) with videos related to
Page
of 11
Sort By:
Journal of Global Oncology
|
September 23, 2018
Cancer Supportive and Survivorship Care in Singapore: Current Challenges and Future Outlook
Kiley Wei-Jen Loh, Terence Ng, Su Pin Choo, et al.
Liver Cancer
|
July 11, 2020
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Localized gastrointestinal stromal tumor of the rectum: An uncommon primary site with prominent disease and treatment-related morbidities
Mohamad Farid, Marcus Jin Fu Lee, Min Hoe Chew, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 16, 2017
Comparison of health state values derived from patients and individuals from the general population
Mihir Gandhi, Ru San Tan, Raymond Ng, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 2012
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
Yeul Hong Kim, Kei Muro, Hirofumi Yasui, et al.
Plos One
|
July 23, 2013
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma
Who-Whong Wang, Soo Fan Ang, Rajneesh Kumar, et al.
Journal of Hepatology
|
November 14, 2009
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
Hung Huynh, Van Chanh Ngo, Heng Nung Koong, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 11, 2022
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Liver Cancer
|
February 28, 2022
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Kennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, et al.
Endocrine-Related Cancer
|
November 7, 2008
Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors
Yu-Cheng Wang, Emerick Gallego-Arteche, Gioia Iezza, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 108) with videos related to
Sort By:
Page
of 11
Journal of Global Oncology
|
September 23, 2018
Cancer Supportive and Survivorship Care in Singapore: Current Challenges and Future Outlook
Kiley Wei-Jen Loh, Terence Ng, Su Pin Choo, et al.
Liver Cancer
|
July 11, 2020
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
Masatoshi Kudo, Kwang-Hyub Han, Sheng-Long Ye, et al.
Molecular and Clinical Oncology
|
March 21, 2014
Localized gastrointestinal stromal tumor of the rectum: An uncommon primary site with prominent disease and treatment-related morbidities
Mohamad Farid, Marcus Jin Fu Lee, Min Hoe Chew, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
August 16, 2017
Comparison of health state values derived from patients and individuals from the general population
Mihir Gandhi, Ru San Tan, Raymond Ng, et al.
Cancer Chemotherapy and Pharmacology
|
August 14, 2012
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy
Yeul Hong Kim, Kei Muro, Hirofumi Yasui, et al.
Plos One
|
July 23, 2013
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma
Who-Whong Wang, Soo Fan Ang, Rajneesh Kumar, et al.
Journal of Hepatology
|
November 14, 2009
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
Hung Huynh, Van Chanh Ngo, Heng Nung Koong, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 11, 2022
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
Kennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Liver Cancer
|
February 28, 2022
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
Kennedy Yao Yi Ng, Sze Huey Tan, Jack Jie En Tan, et al.
Endocrine-Related Cancer
|
November 7, 2008
Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors
Yu-Cheng Wang, Emerick Gallego-Arteche, Gioia Iezza, et al.
Page
of 11